Vis enkel innførsel

dc.contributor.authorAarli, Sander Johan
dc.contributor.authorThomassen, Lars
dc.contributor.authorWaje-Andreassen, Ulrike
dc.contributor.authorLogallo, Nicola
dc.contributor.authorKvistad, Christopher Elnan
dc.contributor.authorNæss, Halvor
dc.contributor.authorFromm, Annette
dc.date.accessioned2021-11-26T13:09:38Z
dc.date.available2021-11-26T13:09:38Z
dc.date.created2021-10-15T21:57:03Z
dc.date.issued2021-08-20
dc.identifier.issn1664-2295
dc.identifier.urihttps://hdl.handle.net/11250/2831692
dc.description.abstractBackground: Carotid artery atherosclerosis is a major risk factor for ischemic stroke. This risk is related to plaque vulnerability and is characterized by plaque morphology, intraplaque neovascularization, and cerebral microembolization. Advanced neurosonology can identify vulnerable plaques and aid in preventing subsequent stroke. We aimed to assess the time course of cerebral microembolization and intraplaque neovascularization during 6 months of follow-up and to explore the utility of advanced neurosonology in patients with acute cerebral ischemia. Methods: Fifteen patients with acute cerebral ischemia and carotid artery plaques underwent comprehensive extra- and intracranial ultrasound examinations, including microemboli detection and contrast-enhanced ultrasound. The examinations were repeated after 3 and 6 months. Results: We examined 28 plaques in 15 patients. The ultrasonographic features of plaque vulnerability were frequent in symptomatic and asymptomatic plaques. There were no significant differences in stenosis degree, plaque composition, plaque surface, neovascularization, or cerebral microembolization between symptomatic and asymptomatic plaques, but symptomatic plaques had a higher number of vulnerable features. None of the patients had recurrent clinical stroke or transient ischemic attack during the follow-up period. We observed a decrease in cerebral microembolization at 6 months, but no significant change in intraplaque neovascularization. Conclusions: In patients with acute cerebral ischemia and carotid artery plaques, cerebral microembolization decreased during 6 months of follow-up, indicating plaque stabilization.en_US
dc.language.isoengen_US
dc.publisherFrontiersen_US
dc.rightsNavngivelse 4.0 Internasjonal*
dc.rights.urihttp://creativecommons.org/licenses/by/4.0/deed.no*
dc.titleThe Course of Carotid Plaque Vulnerability Assessed by Advanced Neurosonologyen_US
dc.typeJournal articleen_US
dc.typePeer revieweden_US
dc.description.versionpublishedVersionen_US
dc.rights.holderCopyright 2021 the authorsen_US
dc.source.articlenumber702657en_US
cristin.ispublishedtrue
cristin.fulltextoriginal
cristin.qualitycode1
dc.identifier.doi10.3389/fneur.2021.702657
dc.identifier.cristin1946360
dc.source.journalFrontiers in Neurologyen_US
dc.identifier.citationFrontiers in Neurology. 2021, 12, 702657.en_US
dc.source.volume12en_US


Tilhørende fil(er)

Thumbnail

Denne innførselen finnes i følgende samling(er)

Vis enkel innførsel

Navngivelse 4.0 Internasjonal
Med mindre annet er angitt, så er denne innførselen lisensiert som Navngivelse 4.0 Internasjonal